JP2006137778A5 - - Google Patents

Download PDF

Info

Publication number
JP2006137778A5
JP2006137778A5 JP2006033099A JP2006033099A JP2006137778A5 JP 2006137778 A5 JP2006137778 A5 JP 2006137778A5 JP 2006033099 A JP2006033099 A JP 2006033099A JP 2006033099 A JP2006033099 A JP 2006033099A JP 2006137778 A5 JP2006137778 A5 JP 2006137778A5
Authority
JP
Japan
Prior art keywords
zolpidem hemitartrate
acid
zolpidem
forming
halide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006033099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006137778A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006137778A publication Critical patent/JP2006137778A/ja
Publication of JP2006137778A5 publication Critical patent/JP2006137778A5/ja
Pending legal-status Critical Current

Links

JP2006033099A 2000-04-24 2006-02-09 ゾルピデムヘミタートレイト Pending JP2006137778A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19929800P 2000-04-24 2000-04-24
US20602500P 2000-05-22 2000-05-22
US22536400P 2000-08-14 2000-08-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001577956A Division JP2003531173A (ja) 2000-04-24 2001-04-24 ゾルピデムヘミタートレイト

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006177160A Division JP2006249105A (ja) 2000-04-24 2006-06-27 ゾルピデムヘミタートレイト

Publications (2)

Publication Number Publication Date
JP2006137778A JP2006137778A (ja) 2006-06-01
JP2006137778A5 true JP2006137778A5 (enExample) 2006-08-10

Family

ID=27394001

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001577956A Withdrawn JP2003531173A (ja) 2000-04-24 2001-04-24 ゾルピデムヘミタートレイト
JP2006033099A Pending JP2006137778A (ja) 2000-04-24 2006-02-09 ゾルピデムヘミタートレイト
JP2006177160A Pending JP2006249105A (ja) 2000-04-24 2006-06-27 ゾルピデムヘミタートレイト

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001577956A Withdrawn JP2003531173A (ja) 2000-04-24 2001-04-24 ゾルピデムヘミタートレイト

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006177160A Pending JP2006249105A (ja) 2000-04-24 2006-06-27 ゾルピデムヘミタートレイト

Country Status (21)

Country Link
US (8) US20020077332A1 (enExample)
EP (1) EP1292304B1 (enExample)
JP (3) JP2003531173A (enExample)
KR (1) KR20030069796A (enExample)
AT (4) ATE335481T1 (enExample)
AU (2) AU2001257213B2 (enExample)
CA (1) CA2406982A1 (enExample)
CZ (1) CZ20023775A3 (enExample)
DE (7) DE04010651T1 (enExample)
DK (1) DK1292304T3 (enExample)
ES (4) ES2248321T3 (enExample)
HR (1) HRP20020909A2 (enExample)
HU (1) HUP0300701A2 (enExample)
IL (1) IL152411A0 (enExample)
NZ (1) NZ522015A (enExample)
PL (1) PL358548A1 (enExample)
PT (3) PT1541146E (enExample)
SE (1) SE5292304T3 (enExample)
SK (1) SK16372002A3 (enExample)
WO (1) WO2001080857A1 (enExample)
YU (1) YU79402A (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018303A2 (en) 2000-08-29 2002-03-07 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
MXPA05006438A (es) 2002-12-18 2005-09-08 Mallinckrodt Inc Derivados de acetamidas de heteroarilo.
WO2004087703A1 (en) * 2003-03-12 2004-10-14 Sun Pharmaceutical Industries Limited Process for the preparation of n,n,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
KR20140104986A (ko) * 2004-02-17 2014-08-29 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
US20080262025A1 (en) * 2004-07-16 2008-10-23 Yatendra Kumar Processes for the Preparation of Zolpidem and its Hemitartrate
NZ563979A (en) * 2005-05-25 2011-02-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
RU2008110477A (ru) * 2005-08-19 2009-09-27 Авентис Фармасьютикалз Инк. (Us) Комбинация снотворного и r (+)-а-(2, 3-диметоксифенил)-1-[2-(4-фторфенил)этил]-4-пиперидинметанола и его терапевтическое применение
BRPI0614943A2 (pt) * 2005-08-19 2011-04-26 Aventis Pharma Inc combinação de um agente hipnótico e composto de bisarila e heteroarila substituìdo e aplicação terapêutica da mesma
JP2009510163A (ja) * 2005-10-03 2009-03-12 マリンクロッド・インコーポレイテッド ヘミ酒石酸および酒石酸ゾルピデム多形の製造方法
JP2009511627A (ja) * 2005-10-17 2009-03-19 マリンクロッド・インコーポレイテッド 錠剤マトリックスにおけるゾルピデムの多形転移
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
CN101460483B (zh) 2006-03-31 2013-05-08 詹森药业有限公司 作为组胺h4受体调节剂的苯并咪唑-2-基嘧啶和吡嗪
US20080132535A1 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized Zolpidem Pharmaceutical Compositions
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
CN103319459A (zh) * 2008-06-30 2013-09-25 詹森药业有限公司 用于制备苯并咪唑-2-基嘧啶衍生物的方法
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
PL3133070T3 (pl) 2009-11-27 2020-01-31 Genzyme Corporation Eliglustat (Genz 112638) jako inhibitor syntazy glukozyloceramidowej do zastosowania w sposobie leczenia choroby Fabry’ego lub choroby Gauchera, przy czym sposób obejmuje dostosowanie indywidualnej dawki terapeutycznej do metabolizmu P450 u pacjenta
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
NZ710640A (en) 2013-03-06 2019-03-29 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
CN116283957A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦水合物及其制备方法
CN116283958B (zh) * 2021-12-03 2026-02-24 山东新时代药业有限公司 唑吡坦共晶体及其制备方法
CN117907368A (zh) * 2024-01-27 2024-04-19 鲁南贝特制药有限公司 一种酒石酸唑吡坦药用晶型d中晶型a、e的定量测定方法
CN118750459B (zh) * 2024-07-22 2025-04-01 常州市武进中医医院 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
IT1130924B (it) * 1980-03-06 1986-06-18 Secifarma Spa Procedimento per la preparazione di spironolattone micronizzato
DE3018940A1 (de) * 1980-05-17 1981-11-26 Hoechst Ag, 6000 Frankfurt Verwendung eines vinylchlorid-pfropf-copolymerisates in der plastisolverarbeitung
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2525601A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
US4675323A (en) * 1985-08-06 1987-06-23 Synthelabo Imidazo(1,2-a)quinoline derivatives useful as anxiolytic agents
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
EP0289371B1 (fr) * 1987-03-27 1991-09-25 Synthelabo Dérivés d'imidazopyridines, leur préparation et leur application en thérapeutique
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
IT1276522B1 (it) * 1995-04-07 1997-10-31 Elena Benincasa Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
ATE297924T1 (de) * 1999-03-25 2005-07-15 Synthon Bv Zolpidem salze
EP1038875B1 (en) * 1999-03-25 2003-06-04 Synthon B.V. Imidazopyridine derivatives and process for making them
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Similar Documents

Publication Publication Date Title
JP2006137778A5 (enExample)
KR102230628B1 (ko) 보르티옥세틴 제조 방법
TW201706271A (zh) 調節蛋白質激酶之化合物的合成
JP2006519818A5 (enExample)
JP2007308494A (ja) 結晶イマチニブ塩基及びその製造方法
CN1227233C (zh) 纯晶形的5－氯－3－(4－甲磺酰基苯基)－6′－甲基－[2,3′]联吡啶及其合成方法
JP2005503386A5 (enExample)
JP2014524442A5 (enExample)
JP2012500819A5 (enExample)
CN101516892A (zh) 制备n-烷基纳曲酮卤化物的方法
JP2016121177A5 (enExample)
JP2005520803A5 (enExample)
JP2010511649A5 (enExample)
CN103570633B (zh) 吉非替尼的制备方法
JP2018522945A5 (enExample)
CN101921260B (zh) 一种伊马替尼的制备方法
WO2017092703A1 (zh) 制备无定型奥贝胆酸的方法
JP2010520251A5 (enExample)
TWI551603B (zh) 培美曲塞二酸之晶型及其製備方法
US20170008848A1 (en) Methods of making netupitant and intermediates thereof
CN106470984B (zh) 制备吡虫啉多晶型的方法
JP2005513122A5 (enExample)
JP2020517674A (ja) ボルチオキセチンＨＢｒ α型を製造するための方法
JP2007502883A5 (enExample)
CN104151238A (zh) 一种直接制备纯8-羟基喹啉铝的方法